"Grupo ALBERTIA es un grupo empresarial formado por profesionales del ámbito geriátrico y gerontológico, especializado en la prestación de servicios de atención a personas mayores en situación de dependencia."

During the past decade, Residencia Albertia Moratalaz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Residencia Albertia Moratalaz" are "Benzodiazepine Withdrawal (Disorder)" (1 trials) and "Malnutrition" (1 trials). Many other conditions were trialed in "Residencia Albertia Moratalaz" in a lesser frequency.

Most popular intervention types in "Residencia Albertia Moratalaz" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control" (1 trials), "Passiflora incarnata" (1 trials) and "Tube Feeding Product" (1 trials). Other intervention names were less common.

The vast majority of trials in "Residencia Albertia Moratalaz" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Residencia Albertia Moratalaz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Residencia Albertia Moratalaz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Residencia Albertia Moratalaz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".